Dr. Cesarman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
525 E 68th St
# 69
New York, NY 10065Phone+1 646-253-2808Fax+1 212-746-3856
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Residency, Pathology-Anatomic and Clinical, 1988 - 1992
- Autonomous Metropolitan University XochimilcoClass of 1981
Certifications & Licensure
- NY State Medical License 1991 - 2025
- American Board of Pathology Anatomic Pathology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2001
Publications & Presentations
PubMed
- Automated detection of Kaposi sarcoma-associated herpesvirus infected cells in immunohistochemical images of skin biopsies.Iftak Hussain, Juan Boza, Robert Lukande, Racheal Ayanga, Aggrey Semeere
Research Square. 2024-08-17 - Rapid, equipment-free extraction of DNA from skin biopsies for point-of-care diagnostics.Jason Cade Manning, Juan Manuel Boza, Ethel Cesarman, David Erickson
Scientific Reports. 2024-06-14 - T Cells Spatially Regulate B Cell Receptor Signaling in Lymphomas through H3K9me3 Modifications.Lucy S Britto, Deepali Balasubramani, Sona Desai, Phunterion Phillips, Neev Trehan
Advanced Healthcare Materials. 2024-06-05
Abstracts/Posters
- Response-Adapted Therapy with Infusional EPOCH Chemotherapy Plus Rituximab in HIV-Associated, B-Cell Non-Hodgkin's LymphomaEthel Cesarman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Safety and Efficacy of Brentuximab Vedotin in Combination with AVD in Stage II-IV HIV-Associated Classical Hodgkin Lymphoma: Results of the Phase 2 Study, AMC 085Ethel Cesarman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Combined EZH2 and BCL2 Inhibitors As Precision Therapy for Genetically Defined DLBCL SubtypesEthel Cesarman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
- Weill Cornell Medicine Awarded NCI Grant for EBV-Related Lymphoma ResearchFebruary 23rd, 2023
- Portable Diagnostic Device Helps African Physicians Diagnose CancerAugust 24th, 2022
- TINY Cancer Detection Device Proves Effective in Uganda TestingSeptember 12th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: